Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.517
https://www.valueinhealthjournal.com/article/S1098-3015(13)02422-4/fulltext
Title :
Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02422-4&doi=10.1016/j.jval.2013.08.517
First page :
A413
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
498